Research Progress--Shanghai Institut of Immunity and Infection, Chinese Academy of Sciences

06

2011-07

A Researcher from Institute Pasteur of Shanghai Published a Review Article about Viral Delivery for Gene Therapy against Cell Movement in Cancer

A review article about viral delivery for gene therapy against cell movement in cancer was published online in a famous internationally journal---Advanced Drug Delivery Reviews(IF：13.577)---in May,2011.The corresponding author is Dr. Viral delivery for cancer gene therapy is a promising approach... A review article about viral delivery for gene therapy against cell movement in cancer was published online in a famous internationally journal ---Advanced Drug Delivery Reviews (IF：13.577)--- in May, 2011. The corresponding author is Dr. Dongming Zhou, a Prinicipal Investigator from Institute ...

21

2011-02

Novel vaccine composition and regimen against lethal avian Influenza infections

A team of researchers, led by Paul Zhou, at Institut Pasteur of Shanghai, Chinese Academy of Sciences, found superior neutralizing antibody response and protection in mice vaccinated with heterologous DNA prime and virus like particle (VLP) boost against HPAI H5N1 virus. The results of this study...

27

2011-01

Viral Sequence Evolution in Chinese Genotype 1b Chronic Hepatitis C Patients Experiencing Unsuccessful Interferon Treatment

The team of Prof. Jin Zhong's at Institut Pasteur of Shanghai, Chinese Academy of Sciences，in collaboration with Prof. Qing Xie's team at Shanghai Ruijin Hospital, analyzed HCV genomic sequence evolution in unsuccessfully treated genotype 1b patients before, during and after the interferon based...

18

2011-01

ECM1 controls Th2 cell egress from lymph nodes through re-expression of S1P1

Recently, a research team, led by Prof. SUN Bing, from Shanghai Institute of Biochemistry and Cell Biology (SIBCB), discovered that ECM1 controls Type 2 helper (Th2) cell egress from lymph nodes through re-expression of S1P1.
　　Th2 cells are differentiated from na？ve CD4+ helper T cells, which...